Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 184 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 517 companies set new 52-week lows.
Citigroup Maintains Neutral on Ovid Therapeutics, Raises Price Target to $2.5
Citigroup analyst Yigal Nochomovitz maintains Ovid Therapeutics (NASDAQ:OVID) with a Neutral and raises the price target from $2.4 to $2.5.
Citigroup Maintains Neutral on Ovid Therapeutics, Lowers Price Target to $2.4
Citigroup analyst Yigal Nochomovitz maintains Ovid Therapeutics (NASDAQ:OVID) with a Neutral and lowers the price target from $4 to $2.4.
Ovid Therapeutics Q1 EPS $(0.23) Down From $2.53 YoY, Sales $1.40M Down From $208.38M YoY
Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.23) per share. This is a 109.09 percent decrease over earnings of $2.53 per share from the same period last year. The company reported $1.40 million in